None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Chronic obstructive pulmonary disease (COPD): meets the diagnostic criteria defined by the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2.COPD inpatients aged =18 years (inclusive, based on the date of informed consent). 3.Medical insurance patients classified under health insurance as chronic obstructive airway disease were enrolled as study subjects, with the DRG groups being: chronic obstructive airway disease with complications or comorbidities, and chronic obstructive airway disease without complications or comorbidities. 4.Subjects who fully understand the study's purpose, nature, methods, and possible adverse reactions, and voluntarily provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Having participated in another drug clinical study within 3 months before the start of this study. 2.Being pregnant or lactating; 3.Any other situation that, in the judgment of the investigator, may compromise the subject's ability to provide informed consent or comply with the study protocol, or could affect the study results or the subject's safety if enrolled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average surplus amount per case for COPD-related DRG groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average total medical cost per case;Average length of hospital stay (ALOS);Average drug cost per case and drug cost ratio (proportion of drug expenses);Antibacterial drug cost ratio (proportion of antibacterial drug costs);Use ratio of key monitored drugs (proportion of key monitored drug costs);Incidence of irrational drug use; | — |
Countries
China
Contacts
Ankang People's Hospital